Official Launch of the NPRA GCP, GLP, BE & EC Inspection Dashboard
The National Pharmaceutical Regulatory Agency (NPRA) is pleased to announce that the NPRA GCP, GLP, BE and EC Inspection Dashboard is now officially live on the NPRA website. The development of this dashboard is part of…
Source: National Pharmaceutical Regulatory Agency · August 7, 2026 at 1:44 AM · AI-assisted report
Single-source
KUALA LUMPUR, 7 AUGUST 2026 —
The National Pharmaceutical Regulatory Agency (NPRA) has officially launched the NPRA GCP, GLP, BE and EC Inspection Dashboard on its website, as part of its efforts to strengthen regulatory oversight and enhance transparency. The dashboard is a centralized platform that provides access to inspection-related information under the scope of Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Bioequivalence (BE) Centre inspections, and Ethics Committee (EC) inspections.
Market Impact
The launch of the dashboard is expected to have a positive impact on the Malaysian market, particularly in the pharmaceutical and healthcare sectors. It will provide stakeholders, including clinical trial sponsors, contract research organizations, and researchers, with easy access to information on NPRA inspection activities, including annual reports and key inspection-related updates.
This increased transparency is likely to promote accountability and stakeholder engagement in the regulation and oversight of clinical research, bioequivalence studies, ethics committees, and GLP facilities in Malaysia.
Details of the dashboard's features and functionality are available on the NPRA website. The dashboard is part of NPRA's commitment to promoting transparency and accountability, in line with the principles of the World Health Organization (WHO) Global Benchmarking Tool. The NPRA encourages all relevant stakeholders to visit the dashboard and use it as a reference for NPRA inspection-related information. The agency's website can be accessed at Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia.
Looking ahead, the launch of the NPRA GCP, GLP, BE and EC Inspection Dashboard is expected to enhance the overall regulatory environment in Malaysia, promoting a more transparent and accountable pharmaceutical industry. As of August 7, 2026, the dashboard is now live, and stakeholders can access the information and updates on NPRA inspection activities.